KKR Invests in Malaysian Healthcare Platform Avisena Healthcare
KKR and Avisena Healthcare announced that funds managed by KKR have entered into a definitive agreement to make a minority investment in the Malaysian private hospital operator. The investment will fund expansion of multi-specialty offerings at Avisena's flagship Shah Alam hospitals and new greenfield hospitals in the Klang Valley; it remains subject to customary closing conditions and no deal value was disclosed. KKR says it has deployed more than US$20 billion in healthcare globally since 2004, with Asia-Pacific holdings including Medical Saigon Group in Vietnam and Metro Pacific Hospital Holdings in the Philippines.
Key figures
- Planned bed additions
- over 300
- Target total beds by 2029
- nearly 600
- Avisena current licensed beds
- more than 250
- Kkr healthcare invested since 2004
- more than US$20 billion
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.